Specialty Pharmacy

Patients with cancer need to be assessed for mental health issues.

Remicade biosimilar safe and effective treating Crohn’s disease and ulcerative colitis.

Counseling sessions and text messages can help patients with rheumatoid arthritis become more active.

Greater education programming needed for patients at-risk for HIV infection.

Analysis of neutrophil behavior enhances understanding of chronic obstructive pulmonary disease.

Microfluidic device can help physicians determine optimal treatment of cancer.

A natural compound could increase the overall health of patients with diabetes, heart disease, and obesity.

Top news of the day from across the health care landscape.

Patients with 2a testicular seminoma show improved outcomes with radiation.

“HIV isn’t the end of the world. HIV is actually just the beginning.”

PEPFAR saw a 33% decrease in funding for HIV/AIDS services.

Treatment attacks brain tumor metabolism at several points.

The Comparative Toxicogenomics Database is able to identify genetically similar diseases and could repurpose medications to treat these conditions.

Accuracy improved in point-of-care urine testing for the screening of tuberculosis in HIV patients.

Top news of the day from across the health care landscape.

A large proportion of cancer patients carry genetic variants of unknown significance.

Inhibiting TGF-beta Receptor Type 1 may have a negative impact on breast cancer therapy.

Rheumatoid arthritis drug shows improvements over methotrexate and Humira in quality of life and physical function.

Improved response rates and extended periods of disease remission found with precision medicine.

Nivolumab blocks the activation of the protein PD-1 to prompt an attack by the immune system.

Rovalpituzumab tesirine (Rova-T) is an antibody-drug conjugate that binds to a protein highly expressed in about two-thirds of SCLC tumors.

Providers need to better inform patients about the risks of heart disease compared with breast cancer.

Patients who underwent surgery and then standard treatment lived 9 months longer than patients who just had the standard treatment.

The compound 2-bromo-palmitate has the ability to inhibit EGFR.

Pembrolizumab found to prevent disease progression in 54.5% of patients with advanced thyroid cancer.

Patients with rheumatoid arthritis taking glucocorticoids in certain doses may have an increased risk of developing diabetes.

Patients with squamous cell mouth cancer with an expressed spectrin gene have a 4.6 times higher death rate.

Recent advances and updates in oncology and cancer drug development.